Scientists from DZNE, University Hospital Bonn (UKB) and the University of Bonn provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer's disease ...

Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 2025 Expansion of discovery efforts based on insights from BioAge’s ...

Keon Johnson and D'Angelo Russell made 3-pointers in the final 10 seconds, and the Brooklyn Nets stunned the Houston Rockets 99-97 on Tuesday night for their first home victory in two months.

First subjects dosed in a Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors, with topline data expected in H2 2025 Phase 2 trial of VTX2735 in participants ...

Advancement of next-generation APJ agonists with discontinuation of azelapragNomination of NLRP3 inhibitor BGE-102 as a development candidate, ...

RICHMOND, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", “the Company”), a clinical-stage biopharmaceutical company developing therapeutic ...